ImmunoGen Inc (NASDAQ:IMGN)

U.S. Markets are not yet open, but IMGN is being traded in the pre-market session. Pre-Market quote »
Data as of Sep 29
 +0.39 / +3.62%
Today’s Change
Today|||52-Week Range
Health Technology

Company Description

ImmunoGen, Inc. is a biotechnology company, which develops novel anticancer therapeutics using its antibody-drug conjugate (ADC) technology. It also have developed engineered linkers that keep the payload firmly attached to the antibody while the whole therapy is circulating through the bloodstream and then release it once the therapy has reached and entered a cancer cell. The company also uses antibody-drug conjugate targeted antibody payload technology together with strong antibody expertise to develop its own product candidates. ImmunoGen was founded in March 1981 and is headquartered in Waltham, MA.

Contact Information

ImmunoGen, Inc.
830 Winter Street
Waltham Massachusetts 02451-1477
P:(781) 895-0600
Investor Relations:



Mutual fund holders65.85%
Other institutional23.89%
Individual stakeholders1.07%

Top Executives

Daniel M. JuniusPresident, Chief Executive Officer & Director
David B. JohnstonChief Financial Officer & Executive Vice President
John M. LambertChief Scientific Officer & Executive VP-Research
James J. O'LearyChief Medical Officer & Vice President
Sandra E. PooleSenior Vice President-Technical Operations

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.